Plasma proteolytic activity in liver transplant rejection

Transplant International

Volumn 12, Issue 2, 1999, Pages 100-107

  Scholz, T ^a   Gallimore, M J ^a   Backman L ^b   Mathisen, O ^a   Bergan, A ^a   Klintmalm, G B ^c   Aasen, A O ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Liver transplantation, proteolytic activity, rejection; Proteolytic activity, rejection, liver transplantation; Rejection, liver transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA 2 ANTIPLASMIN; ANTITHROMBIN III; ASPARTATE AMINOTRANSFERASE; KALLIKREIN; KALLIKREIN INHIBITOR; PLASMIN; PLASMINOGEN; PREKALLIKREIN; PROTHROMBIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD; BLOOD CLOTTING; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; GRAFT REJECTION; HUMAN; HUMAN TISSUE; ISCHEMIA; KIDNEY BIOPSY; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MALE; PLASMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN DEGRADATION; SCHOOL CHILD;

ADOLESCENT; ADULT; ANTIFIBRINOLYTIC AGENTS; ANTIPLASMIN; ANTITHROMBIN III; BLOOD COAGULATION FACTORS; CHILD; FEMALE; GRAFT REJECTION; HUMANS; KALLIKREINS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; PLASMIN; PLASMINOGEN; POSTOPERATIVE PERIOD; PREKALLIKREIN; PROTHROMBIN; RETROSPECTIVE STUDIES; SERINE ENDOPEPTIDASES;

EID: 0032919415     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001470050193     Document Type: Article

References (33)

1. Aasen AO (1985) The proenzyme functional inhibition index. A new parameter for evaluation of the severely injured and septic patient. Acta Chir Scand Suppl 522: 211-231
2. Aasen AO, Risberg B (1990) Role of proteases in surgical intensive care patients. In: Aasen AO, Risberg B (eds) Surgical pathophysiology, Harwood, London, pp 211-226
3. Aasen AO, Erichsen NS, Gallimore MJ, Amundsen E (1980) Studies on components of the plasma kallikreinkinin system in plasma samples from normal individuals and patients with septic shock. Adv Shock Res 4: 1
4. Aasen AO, Kierulf P. Strømme JH (1982) Methodological considerations on chromogenic peptide substrate assays and application on automated analyzers. Acta Chir Scand Suppl 509: 17-22
5. Adams DH, Neuberger JM (1990) Patterns of graft rejection following liver transplantation (comments). J Hepatol 10: 113-119
6. Amundsen E, Gallimore MJ, Aasen AO, Larsbraten M, Lyngaas K (1978) Activation of human plasma prekallikrein: influence of activators, activation time and temperature and inhibitors. Thromb Res 13: 625
7. Batts K (1996) Liver allograft rejection: current status of classification and grading. Transplant Proc 28: 453-456
8. De La Cadena RA, Wachlfogel YT, Colman RW (1994) Contact activation pathway: inflammation and coagulation. In: Colman RW, Hirsh J, Marder VJ, Salzman EW (eds) Hemostasis and thrombosis: basic principles and clinical practice. J. B. Lippincott, Philadelphia, pp 219-233
9. Demetris AJ, Qian SG, Sun H, Fung JJ (1990) Liver allograft rejection: an overview of morphologic findings. Am J Surg Pathol 1: 49-63
10. Fischbach P, Scharrer I (1993) Therapeutic impact of orthotopic liver transplantation on disorders of hemostasis (review). Semin Thromb Hemost 19: 250-257
11. Gerlach H, Slama KJ, Bechstein WO, Lohmann R, Hintz G, Abraham K, Neuhaus P Falke K (1993) Retrospective statistical analysis of coagulation parameters after 250 liver transplantations. Semin Thromb Hemost 19: 223-232
12. Grand RJ, Turnell AS, Grabham PW (1996) Cellular consequences of thrombin-receptor activation. Biochem J 313: 353-368
13. Kang Y (1993) Coagulation and liver transplantation. Transplant Proc 25: 2001-2005
14. Klintmalm GB, Nery JR, Husberg BS, Gonwa TA, Tillery GW (1989) Rejection in liver transplantation. Hepatology 10: 978-985
15. Lewis JH, Bontempo FA, Awad SA, Kang YG, Kiss JE, Ragni MV, Spero JA, Starzl TE (1989) Liver transplantation: intraoperative changes in coagulation factors in 100 first transplants. Hepatology 9: 710-714
16. Maddrey WC (1988) Transplantation of the liver. Curr Top Gastroenterol: 167-189
17. Mammen EF (1997) Hemostasis alterations in liver disorders. Biomed Prog 10: 1-6
18. Miki C, Iriyama K, Gunson BK, Mayer D, Buckels JAC, McMaster P (1997) Influence of intraoperative blood loss on plasma levels of cytokines and endotoxin and subsequent graft liver function. Arch Surg 132: 136-141
19. Moia M, Martinelli I, Mannucci PM (1993) Laboratory measures of hemostasis for monitoring liver graft function. Semin Thromb Hemost 19: 238-242
20. Mor E, Jennings L, Gonwa TA, Holman MJ, Gibbs J, Solomon H, Godstein RM, Husberg BS, Watemberg IA, Klintmalm GB (1993) The impact of operative bleeding on outcome in transplantation of the liver. Surg Gynecol Obstet 176: 219-227
21. Omland E, Mathisen O (1991) Hepatic and splanchic metabolism of plasma protoelytic enzymes before, during and after clamping of the hepatic artery and portal vein. Transplantation 52: 972-979
22. Palareti G, Legnani C, Maccaferri M, Gozzetti G, Mazziotti A, Martinelli G, Zanello M, Sama C, Coccheri S (1991) Coagulation and fibrinolysis in orthotopic liver transplantation: role of the recipient's disease and use of antithrombin III concentrates. Hemotasis 21: 68-76
23. Porte RJ (1993) Coagulation and fibrinolysis in orthotopic liver transplantation: current views and insights. Semin Thromb Hemost 19: 191-196
24. Porte RJ, Knot EA, Bontempo FA (1989) Hemostasis in liver transplantation, (review). Gastroenterology 97: 488-501
25. Rifkin DB (1997) Cross-talk among proteases and matrix in the control of growth factor action. Fibrinol Proteol 11: 3-9
26. Roberts HR, Cederbaum AI (1972) The liver and blood coagulation: physiology and pathology. Gastroenterology 63: 297-320
27. Roenholm E, Tomasdottir H, Runeborg J, Bengtsson A, Bengtson J-P, Stenqvist O, Friman S (1994) Complement system activation during orthotopic liver transplantation in man. Transplantation 57: 1594-1597
28. Scholz T, Backman L, Mathisen O, Buo L, Karlsrud T, Johanson HT, Bergan A, Klintmalm GB, Aasen AO (1995) Activation of the pasma contact system and hemodynamic changes after graft revascularization in liver transplantation. Transplantation 60: 36-40
29. Schrader J, Gallimore MJ, Eisenhauer T, Isemer FE, Schoel G, Wurneke G, Brüggeman M, Scheler F (1988) Parameters of the kallikrein-kinin, coagulation and fibrinolytic systems as early indicators of kidney transplant rejection. Nephron 48: 183-189
30. Stahl RL, Duncan A, Hooks MA, Henderson JM, Millikan WJ, Warren WD (1990) A hypercoagulahle state follows orthotopic liver transplantation. Hepatolgy 12: 553-558
31. Tomasdottir H, Henriksson B-Å, Bengtson J-P, Bengtsson A, Stenqvist O, Persson H (1993) Complement actvation during liver transplantation. Transplantation 55: 799-802
32. Velasco F, Villalba R, Fernandez M, Mata M de la, Roman J, Ruhio V, Rufian S, Varo E, Pera C, Torres A (1992) Diminished anticoagulant and fibrinolytic activity following liver transplantation. Transplantation 53: 1256-1261
33. Wiesner RH (1994) Advances in diagnosis, prevention, and management of hepatic allograft rejection. Clin Chem 40: 2174-2185